Ziarco
About:
Ziarco develops therapeutic agents for treating inflammatory and allergic diseases.
Website: http://www.ziarcopharma.com
Top Investors: Innovate UK, New Enterprise Associates, Sofinnova Investments, Pfizer Venture Investments, Amgen Ventures
Description:
Ziarco, Inc. develops therapeutic agents for treating inflammatory and allergic diseases. The company was founded in 2012 and is based in Palo Alto, California.
Total Funding Amount:
$43.5M
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2012-01-01
Contact Email:
contact(AT)ziarcopharma.com
Founders:
Arif Shivji, Mike Yeadon, Wai Liu
Number of Employees:
1-10
Last Funding Date:
2014-11-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai